Evidence map›Paper›PMID 27777508›Full record

ArticleTropical medicine and health2016

Pathogenic potential and growth kinetics of Muko virus in mice and human-derived cells.

Gianne Eduard L Ulanday, Satoshi Shimada, Ngwe Tun Mya Myat, Takeshi Nabeshima, Kouichi Morita, Daisuke Hayasaka

Abstract read
In one paragraph

Article in Tropical medicine and health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gianne Eduard L UlandayDepartment of Virology, Institute of Tropical Medicine (NEKKEN), 1-12-4 Sakamoto, Nagasaki, 852-8523 Japan.
Satoshi ShimadaDepartment of Virology, Institute of Tropical Medicine (NEKKEN), 1-12-4 Sakamoto, Nagasaki, 852-8523 Japan ; Leading Graduate School Program, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523 Japan.
Ngwe Tun Mya MyatDepartment of Virology, Institute of Tropical Medicine (NEKKEN), 1-12-4 Sakamoto, Nagasaki, 852-8523 Japan.
Takeshi NabeshimaDepartment of Virology, Institute of Tropical Medicine (NEKKEN), 1-12-4 Sakamoto, Nagasaki, 852-8523 Japan.
Kouichi MoritaDepartment of Virology, Institute of Tropical Medicine (NEKKEN), 1-12-4 Sakamoto, Nagasaki, 852-8523 Japan ; Leading Graduate School Program, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523 Japan.
Daisuke HayasakaDepartment of Virology, Institute of Tropical Medicine (NEKKEN), 1-12-4 Sakamoto, Nagasaki, 852-8523 Japan ; Leading Graduate School Program, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523 Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTicks have been long known as vectors of various pathogens, some of which can cause high fatality rates among infected individuals. Our enhanced tick surveillance around Nagasaki, Japan, led to the isolation and identification of a new strain of a recently identified

methodsIn this study, we explored the in vivo pathogenicity of a newly isolated MUV strain (MUV-Hay) using a mouse model and demonstrated its growth kinetics in human-derived cells.

resultsOur results showed the ability of MUV-Hay to propagate in human neuronal and renal cells with some cytopathic effect. Furthermore, intracerebral inoculation of our new isolate caused high mortality in adult A129 mice.

conclusionOur study provided a first step to experimentally test the hypothesis, that MUV can replicate and produce cytopathic effect in human cells and demonstrate virulence in adult mice.

Indexed as

Human-derived cellsMouse modelMuko virusTick-borne virus

Identifiers

PMID27777508
PMCPMC5057483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.